These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27362551)

  • 41. Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis.
    Soliman AF; Abouelkhair MM; Hasab Allah MS; El-Kady NM; Ezzat WM; Gabr HA; Elsayed EH; Saleh AI; Kamel A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):295-301. PubMed ID: 30678453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
    Zhu ZY; Yuan M; Yang PP; Xie B; Wei JZ; Qin ZQ; Qian Z; Wang ZY; Fan LF; Qian JY; Tan YL
    World J Surg Oncol; 2022 Jun; 20(1):192. PubMed ID: 35689233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: a prospective cohort study.
    Morimoto M; Numata K; Kondo M; Moriya S; Morita S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Mar; 82(3):497-503. PubMed ID: 23068563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.
    Vogl TJ; Qian J; Tran A; Oppermann E; Naguib NN; Korkusuz H; Nour Eldin NE; Bechstein WO
    Diagn Interv Radiol; 2017; 23(2):150-155. PubMed ID: 28185998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L; Ke Q; Lin N; Huang Q; Zeng Y; Liu J
    Int J Hyperthermia; 2019; 36(1):1288-1296. PubMed ID: 31852267
    [No Abstract]   [Full Text] [Related]  

  • 47. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
    Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
    Miyamoto N; Kanaya M; Fujii T; Kato H; Kudo K; Kinota N
    Jpn J Radiol; 2021 Apr; 39(4):376-386. PubMed ID: 33150469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm.
    Zaitoun MMA; Elsayed SB; Zaitoun NA; Soliman RK; Elmokadem AH; Farag AA; Amer M; Hendi AM; Mahmoud NEM; Salah El Deen D; Alsowey AM; Shahin S; Basha MAA
    Int J Hyperthermia; 2021; 38(1):248-256. PubMed ID: 33615957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.
    Chiang J; Rajendran PS; Hao F; Sayre J; Raman SS; Lu DSK; McWilliams JP
    Diagn Interv Radiol; 2023 Nov; 29(6):805-812. PubMed ID: 37665139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas.
    Wang ZJ; Wang MQ; Duan F; Song P; Liu FY; Chang ZF; Wang Y; Yan JY; Li K
    World J Gastroenterol; 2013 Jul; 19(26):4192-9. PubMed ID: 23864783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma.
    Ding J; Jing X; Liu J; Wang Y; Wang F; Wang Y; Du Z
    Eur J Radiol; 2013 Sep; 82(9):1379-84. PubMed ID: 23726122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T; Hayashi S; Shimizu J; Dono K; Nakata S; Sato M; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2371-3. PubMed ID: 20037426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma.
    Liu C; Liang P; Liu F; Wang Y; Li X; Han Z; Liu C
    Int J Hyperthermia; 2011; 27(7):654-62. PubMed ID: 21966941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
    Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
    JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.